These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32451543)

  • 1. Graves Orbitopathy.
    Natali S; Shogan P
    J Am Osteopath Assoc; 2020 Jun; 120(6):425. PubMed ID: 32451543
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation and management of Graves' orbitopathy.
    Lee HB; Rodgers IR; Woog JJ
    Otolaryngol Clin North Am; 2006 Oct; 39(5):923-42, vi. PubMed ID: 16982255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of Graves' orbitopathy. Comments on the EUGOGO consensus statement].
    Bednarczuk T; Bar-Andziak E; Hubalewska-Dydejczyk A; Waligórska A; Górska M; Myśliwiec J; Jarzab B; Karczmarzyk R; Zawadzka A; Garmol D; Kecik D; Królicki L; Plazińska MT; Krzeski A; Krzyzanowska-Swiniarska B; Lewiński A; Milewicz A; Daroszewski J; Placzkiewicz-Jankowska E; Pilarska K; Skórski M; Wiechno W; Sowiński J; Syrenicz A; Szafilk J; Wanyura H; Zgliczński W; Jastrzebska H; Nauman J
    Endokrynol Pol; 2009; 60(4):312-30. PubMed ID: 19753546
    [No Abstract]   [Full Text] [Related]  

  • 4. [Graves' Orbitopathy].
    Eckstein A; Esser J; Mattheis S; Berchner-Pfannschmidt U
    Klin Monbl Augenheilkd; 2016 Dec; 233(12):1385-1407. PubMed ID: 27871109
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of patients with Graves' orbitopathy: initial assessment, management outside specialized centres and referral pathways.
    Orgiazzi J
    Clin Endocrinol (Oxf); 2016 May; 84(5):662-3. PubMed ID: 26866718
    [No Abstract]   [Full Text] [Related]  

  • 6. Graves' orbitopathy: Diagnosis and treatment.
    Drui D; Du Pasquier Fediaevski L; Vignal Clermont C; Daumerie C
    Ann Endocrinol (Paris); 2018 Dec; 79(6):656-664. PubMed ID: 30177259
    [No Abstract]   [Full Text] [Related]  

  • 7. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.
    Bartalena L; Baldeschi L; Dickinson A; Eckstein A; Kendall-Taylor P; Marcocci C; Mourits M; Perros P; Boboridis K; Boschi A; Currò N; Daumerie C; Kahaly GJ; Krassas GE; Lane CM; Lazarus JH; Marinò M; Nardi M; Neoh C; Orgiazzi J; Pearce S; Pinchera A; Pitz S; Salvi M; Sivelli P; Stahl M; von Arx G; Wiersinga WM;
    Eur J Endocrinol; 2008 Mar; 158(3):273-85. PubMed ID: 18299459
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combined idiopathic orbital inflammation and Graves' orbitopathy].
    Ciechanowski PP; Töteberg-Harms M; Pangalu A; Chaloupka K
    Klin Monbl Augenheilkd; 2012 Apr; 229(4):466-7. PubMed ID: 22496035
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis and management of thyroid orbitopathy.
    Rose JG; Burkat CN; Boxrud CA
    Otolaryngol Clin North Am; 2005 Oct; 38(5):1043-74. PubMed ID: 16214573
    [No Abstract]   [Full Text] [Related]  

  • 10. Asymmetric Graves' Orbitopathy.
    Panagiotou G; Perros P
    Front Endocrinol (Lausanne); 2020; 11():611845. PubMed ID: 33391188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thyroid associated orbitopathy: from diagnosis to treatment].
    Hamédani M; Obéric A
    Rev Med Suisse; 2013 Jan; 9(368):66-71. PubMed ID: 23367708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease.
    Vargason CW; Chelnis JG; Barahimi BI; Mawn LA
    Semin Ophthalmol; 2016; 31(4):409-14. PubMed ID: 27385363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal management of Graves orbitopathy: a multidisciplinary approach.
    Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
    Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial. Graves' orbitopathy.
    von Arx GF
    Orbit; 2009; 28(4):209-13. PubMed ID: 19839876
    [No Abstract]   [Full Text] [Related]  

  • 15. Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy.
    Bartalena L; Baldeschi L; Dickinson AJ; Eckstein A; Kendall-Taylor P; Marcocci C; Mourits MP; Perros P; Boboridis K; Boschi A; Currò N; Daumerie C; Kahaly GJ; Krassas G; Lane CM; Lazarus JH; Marinò M; Nardi M; Neoh C; Orgiazzi J; Pearce S; Pinchera A; Pitz S; Salvi M; Sivelli P; Stahl M; von Arx G; Wiersinga WM
    Thyroid; 2008 Mar; 18(3):333-46. PubMed ID: 18341379
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyroid eye disease: a review.
    Weiler DL
    Clin Exp Optom; 2017 Jan; 100(1):20-25. PubMed ID: 27701774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical Guidelines Management of Graves Ophthalmopathy.
    Subekti I; Soewondo P; Soebardi S; Darmowidjojo B; Harbuwono DS; Purnamasari D; Tarigan TJE; Wisnu W; Tahapary DL; Kurniawan F; Sidik M; Nusanti S; Dewiputri S; Suharko H; Suardana GG; Suroyo I; Wulani V; Siswoyo AD; Gondhowiardjo S; Kodrat H
    Acta Med Indones; 2019 Oct; 51(4):364-371. PubMed ID: 32041923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy-resistant thyroid diseases. 1.Graves' ophthalmopathy].
    Hiromatsu Y
    Nihon Naika Gakkai Zasshi; 2010 Apr; 99(4):755-62. PubMed ID: 20578362
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current management of endocrine orbitopathy].
    Ponto KA; Kahaly GJ
    Med Klin (Munich); 2008 Oct; 103(10):717-30; quiz 729-30. PubMed ID: 18936897
    [No Abstract]   [Full Text] [Related]  

  • 20. Thyroid Orbitopathy.
    Wang Y; Tooley AA; Mehta VJ; Garrity JA; Harrison AR; Mettu P
    Int Ophthalmol Clin; 2018; 58(2):137-179. PubMed ID: 29517649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.